Brian McNamara
TV Actor
Brian McNamara was born in Long Island, New York, United States on November 21st, 1960 and is the TV Actor. At the age of 63, Brian McNamara biography, profession, age, height, weight, eye color, hair color, build, measurements, education, career, dating/affair, family, news updates, movies, TV shows, and networth are available.
Date of Birth
November 21, 1960
Nationality
United States
Place of Birth
Long Island, New York, United States
Age
63 years old
Zodiac Sign
Scorpio
Profession
Actor, Film Actor, Film Director, Film Producer, Producer, Television Actor
Brian McNamara Height, Weight, Eye Color and Hair Color
At 63 years old, Brian McNamara has this physical status:
Height
Not Available
Weight
Not Available
Hair Color
Light brown
Eye Color
Not Available
Build
Athletic
Measurements
Not Available
Brian McNamara Religion, Education, and Hobbies
Religion
Not Available
Hobbies
Not Available
Education
Not Available
Brian McNamara Spouse(s), Children, Affair, Parents, and Family
Spouse(s)
Not Available
Children
2
Dating / Affair
Not Available
Parents
Not Available
Revenues in Haleon slowed due to currency headwinds
www.dailymail.co.uk,
February 29, 2024
Revenues increased by 4.1 percent to £11.3 billion in 2023, compared to 13.8 percent in the previous year. Although the firm's organic revenues increased by 8 percent, it was still suffering from volatile currency movements, mainly from sterling appreciation against emerging market currencies like the Argentine Peso and Chinese Renminbi.
ChapStick will be sold to a private equity-backed company in the United States
www.dailymail.co.uk,
January 25, 2024
Haleon, the company behind brands like Panadol and Sensodyne, has decided to sell Lip balm brand ChapStick to a US-based private equity firm Yellow Wood Partners for about $80 million, or nearly £63 million in cash, as a result. Brian McNamara, Haleon's chief executive, said that although ChapStick was a well-loved brand by customers, it was no longer a primary concern for the company. 'Selling the brand helps us to streamline our operations and pay down debt more quickly,' McNamara said on Thursday.
When FX movements knock sales, Haleon suffers a weaker painkiller demand
www.dailymail.co.uk,
November 2, 2023
Haleon shares dropped on Thursday as the company barely met third-quarter earnings estimates. In North America, the Panadol company, the world's biggest consumer healthcare company, was struggling with poor demand for painkillers, digestive health, and vitamin supplements. Haleon maintained its full-year earnings and revenue estimates, but it took a hit of nearly 3.5 percent on sales and 6 percent to 6.5 percent on adjusted operating income due to currency swings.